8-K
false00018024500001802450mspr:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150PerShareMember2022-06-302022-06-3000018024502022-06-302022-06-300001802450us-gaap:CommonClassAMember2022-06-302022-06-300001802450mspr:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00001PerShareMember2022-06-302022-06-30

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2022

 

 

MSP Recovery, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39445

84-4117825

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2701 Le Jeune Road

Floor 10

 

Coral Gables, Florida

 

33134

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (305) 614-2222

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A common stock, par value $0.0001 per share

 

MSPR

 

The NASDAQ Global Market

Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share

 

MSPRW

 

The NASDAQ Global Market

Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $0.0001 per share

 

MSPRZ

 

The NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


 

 


Item 1.01 Entry into a Material Definitive Agreement.

On June 30, 2022, MSP Recovery, Inc., a Delaware corporation (“MSPR” or the “Company”), entered into an Assignment and Sale of Proceeds Agreement (the “Assignment Agreement”) and a Recovery Services Agreement (the “Services Agreement” and collectively, the “Agreements”) with the Prudent Group (“Prudent”) in order to monetize up to $250 million of the value of the Company’s net recovery interest in claim demand letters that the Company has commenced sending to insurers who admitted they had primary payer responsibility for the underlying accidents to the federal government (“MSPR’s Net Recovery Proceeds”).

 

Pursuant to the Agreements, at the Company’s sole and absolute discretion, the Company has the right to direct Prudent to acquire, on a non-recourse basis, a percentage of MSPR’s Net Recovery Proceeds, up to an aggregate of $250 million, at a purchase price of 90% of the paid amount of such claim.

 

Under the Services Agreement, the Company will service and recover on the demand letters and will retain any revenues generated in excess of the amount received from Prudent, plus up to an 18% annual return on the amount Prudent paid for MSPR’s Net Recovery Proceeds. Prudent may terminate the Services Agreement upon sixty (60) days prior written notice to the Company.

 

The Agreements contain customary representations, warranties and covenants of the Company and Prudent, including indemnification for breach of the Agreements, subject to certain limitations.

 

The disclosure set forth in this Item 1.01 is intended to be a summary only and is qualified in its entirety by reference to the Agreements, copies of which will be filed as exhibits to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.

Item 7.01 Regulation FD Disclosure.

On July 4, 2022, the Company issued a press release announcing the entrance into the Agreements. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information in this Item 7.01, including Exhibit 99.1, and the information set forth therein, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings.

 

The press release contains forward-looking statements. Such forward-looking statements are based on information presently available to the Company’s management and are current only as of the date made. Actual results could also differ materially from those anticipated as a result of a number of factors, including, but not limited to, those discussed in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports file by it with the Securities and Exchange Commission. For those reasons, undue reliance should not be placed on any forward-looking statement. The Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits.

 

Exhibit

Number

 

Exhibit

99.1

 

Press Release dated July 4, 2022

104

 

Cover Page Interactive Data File (formatted as Inline XBRL).

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

MSP RECOVERY, INC.

 

 

 

 

Date:

July 7, 2022

By:

/s/ Calvin Hamstra

 

 

 

Name: Calvin Hamstra
Title: Chief Financial Officer

 


EX-99.1

 

MSP RECOVERY ENTERS INTO AGREEMENT WITH PRUDENT GROUP

TO MONETIZE UP TO $250 MILLION IN CERTAIN PROPERTY & CASUALTY CLAIM RECOVERIES ON A NON-RECOURSE BASIS

 

Agreement Relates to Previously Announced Individual Claim Demand Letters Being Sent by MSPR to Property and Casualty Insurers

 

CORAL GABLES, Fla., July 04, 2022 -- MSP Recovery, Inc. (NASDAQ: MSPR) (“MSPR” or the “Company”) today announced that the Company has entered into an agreement to monetize up to $250 million of the value of MSPR’s Net Recovery Proceeds, as defined below, with Prudent Group.
 

“This agreement is part of a more strategic relationship to provide an attractive access point to invest in the U.S. healthcare industry for our European investors,” says Dennis Klemming, Founder of The Prudent Group, a global alternative asset management firm pursuing diverse and unique opportunity sets across different industry sectors, asset classes, and geographies, including acquiring receivables from healthcare entities.

 

As previously announced on June 13, 2022, MSPR has commenced sending individual claim demand letters to insurers who admitted they had primary payer responsibility for the underlying accidents to the federal government. As a result of these efforts, MSPR has experienced an increase in the volume of payments received from such responsible parties. The agreement with Prudent Group relates specifically to these demand letters and gives MSPR the right to direct, at MSPR’s discretion, the Prudent Group to acquire a percentage of MSPR’s recovery rights in the individual claim demand letters on a non-recourse basis – up to an aggregate total of $250 million.

 

How it works?

 

MSPR acquires the assignments of its recoveries from health insurance payors, healthcare providers and self-funded entities, and uses its proprietary multi-level data analytics system to secure recoveries from responsible parties. MSPR typically pays the assignors 50% of such recoveries (the “Assignor Interest”) and retains the rest (the “MSPR Recovery Proceeds”). The MSPR Recovery Proceeds are subject to a legal services agreement pursuant to which MSP Recovery Law Firm retains a forty percent (40%) fee on all of the MSPR Recovery Proceeds, which fee is split amongst various co-counsel. MSPR is entitled to thirty percent (30%) of the MSPR Recovery Proceeds arising from its recovery efforts (“MSPR’s 30% Interest” or MSPR’s Net Recovery Proceeds”), including those generated by the individual claim demand letters.

 

Pursuant to the agreement with Prudent Group, at MSPR’s sole and absolute discretion, Prudent Group will acquire, on a non-recourse basis, MSPR’s Net Recovery Interest relating to the individual claim demand letters. Specifically, Prudent Group has committed to acquire up to $250 million in MSPR’s 30% Interest at a purchase price of 90% of the paid amount of such claim (i.e., 90% of MSPR’s 30% Interest). The individual demand letters are denominated at a billed amount, which is generally a multiple of the paid amount.

 

In conjunction with the agreement, MSPR will service and recover on the demand letters and will retain any revenues generated in excess of the amount received from Prudent Group, plus up to an 18% annual return on the amount Prudent Group paid for MSPR’s Net Recovery Proceeds.

 

By way of example, if the paid amount of a claim set forth in the demand letters is $1,000, MSPR’s Net Recovery Interest is $300. If directed by MSPR, Prudent Group would acquire MSPR’s Net Recovery Interest at a rate of 90% of $300, totaling $270 (the “Principal”). MSPR would then service the claims in exchange for rights to recoveries in excess of Prudent Group’s Principal and return. If a recovery is made within the first 90 days of Prudent Group’s acquisition of MSPR’s Net Recovery Interest, then Prudent Group would be paid its Principal invested amount of $270 plus a 4.5% return, or $282.15, and MSPR would be entitled to the remainder of MSPR’s Net Recovery Interest. For each month after the first 90 days, Prudent Group would earn an additional 1.5% return on the Principal amount invested, and MSPR would be entitled to the remainder of MSPR’s Net Recovery Interest. For reference, MSPR’s settlement with Ocean Harbour resulted in recoveries at 3.5x the paid amount of the claim.

 


“In addition to the long-term investment relationship with Virage Capital Management, this agreement with Prudent Group is one of many examples of the real value of MSPR’s assets and illustrates the many ways in which those assets can be monetized on a non-recourse basis,” said MSPR Founder and CEO, John H. Ruiz. “More than 90% of the value related to the $87 billion in funneled claims owned by MSPR as of December 2021 relates to property and casualty cases. We are thrilled to enter into this ground-breaking $250 million deal with Prudent Group, which can monetize those claims at 90% of the paid amount.”

 

About MSP Recovery
 

Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions, while innovating technologies to help save lives. For more information, visit: www.msprecovery.com

 

Forward Looking Statements
 

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSPR in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for MSPR to predict or identify all such events or how they may affect it. MSPR has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, MSPR’s ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; litigation results; the validity of the assignments of claims to MSPR; the ability to successfully expand the scope of MSPR’s claims or obtain new data and claims from MSPR’s existing assignor base or otherwise; MSPR’s ability to innovate and develop new solutions, and whether those solutions will be adopted by MSPR’s existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy; and those other factors included in MSPR’s Annual reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.